Roche Diagnostics Ltd

Lobbying Organisation Roche Diagnostics Ltd

Date published 06 May, 2025

Relevant Matter Public policy or programme

Public Policy Area Health

Period 1 Jan, 2025 to 30 Apr, 2025

Specific Details Meetings about the role near patient testing (point of care testing) can play in strengthening existing and future primary care policies

Intended results Highlight awareness on the value of this testing and begin an engagement with the HSE to develop possible pilot projects

Name of person primarily responsible for lobbying on this activity Leonard Marshall

Did any Designated Public Official(DPO) or former Designated Public Official(DPO) carry out lobbying activities on your behalf in relation to this return? You must include yourself, and answer Yes, if you are a current DPO or a DPO at any time in the past. (What is a Designated Public Official?) No

Did you manage or direct a grassroots campaign? No

Was this lobbying done on behalf of a client? No

Lobbying activity

The following activities occurred for this specific Subject Matter Area.

Meeting (2-5)

Lunchtime meetings to discuss the role that near patient testing (point of care testing) can play in strengthening existing and future primary care policies, such as the Chronic Disease Managment programme.

Email (1)

email of a briefing document sent just before Christmas to other re-elected TDs to additional recently re-elected TD (Mary Butler)

Designated public officials lobbied

The following DPOs were lobbied during this return period on this specific Subject Matter Area. These DPOs were involved in at least one of the Lobbying Activities listed above, but not necessarily all of them. As returns are specific to a Subject Matter Area the above Lobbying Activities may be associated with multiple returns.

Mary Butler Minister of State (Department of Health)

Robert Watt Secretary General (Department of Health)

Pat Healy National Director for Service and Schemes (Health Service Executive)